Zydus Lifesciences added 1.10% to Rs 987.60 after the company said that the USFDA had granted orphan drug designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic ...

Zydus’ Usnoflast receives US FDA orphan drug designation to treat amyotrophic lateral sclerosis: Our Bureau, Mumbai Thursday, January 23, 2025, 12:15 Hrs [IST] Zydus, a leading, ...

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...

With the hold lifted, Amylyx can begin screening and enrolling for its Phase 1 LUMINA trial, which will test AMX0114 in ALS ...

CREAL's next-generation light field display developed for Augmented Reality (AR) glasses is now ready for integration. By replicating real-world light to deliver genuine focus depth, the display ...

Specialized breast oncology practice Complete Breast Care is pleased to announce its integration with Advanced Reconstructive Surgery Alliance (ARSA), expanding its surgical expertise in the ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Health anxiety can amplify the symptoms of bipolar disorder. Here’s how mindfulness, therapy, and support can help calm the storm. I’ve always been a bit of a worrier. But when I was 23, my anxiety ...

The former Bison player was diagnosed with the disease at age 34. He has reunited with a former teammate, coach John Griffin ...

Brain-computer interfaces translate neural signals into actions, revolutionizing healthcare and enhancing communication for individuals with disabilities.

Investment analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Eledon Pharmaceuticals in a research report issued on Tuesday, January 21st. Cantor Fitzgerald ...